Companies / Health Care / Health Care Equipment
Idexx Laboratories stock buybacks
IDXX$1.2Bbought back in the 12 months to Jun 30, 2026
Idexx Laboratories bought back $1.2B of its stock in the last twelve months, $1.1B more than it paid out in stock compensation. Its share count is down 2.1% from a year earlier.
Show as table
| Period | Value |
|---|---|
| Q3 '20 | $0 |
| Q4 '20 | $0 |
| Q1 '21 | $132.3M |
| Q2 '21 | $188.5M |
| Q3 '21 | $181.2M |
| Q4 '21 | $244.8M |
| Q1 '22 | $266.3M |
| Q2 '22 | $306.8M |
| Q3 '22 | $172.6M |
| Q4 '22 | $74.0M |
| Q1 '23 | $0 |
| Q2 '23 | $0 |
| Q3 '23 | $35.1M |
| Q4 '23 | $36.9M |
| Q1 '24 | $154.8M |
| Q2 '24 | $215.5M |
| Q3 '24 | $220.8M |
| Q4 '24 | $246.0M |
| Q1 '25 | $400.9M |
| Q2 '25 | $338.1M |
| Q3 '25 | $240.2M |
| Q4 '25 | $237.8M |
| Q1 '26 | $351.0M |
| Q2 '26 | $346.8M |
Show as table
| Period | Value |
|---|---|
| Q3 '20 | 86.7M |
| Q4 '20 | 87.1M |
| Q1 '21 | 86.9M |
| Q2 '21 | 86.7M |
| Q3 '21 | 86.5M |
| Q4 '21 | 86.2M |
| Q1 '22 | 85.6M |
| Q2 '22 | 84.9M |
| Q3 '22 | 84.1M |
| Q4 '22 | 83.9M |
| Q1 '23 | 84.0M |
| Q2 '23 | 84.0M |
| Q3 '23 | 84.0M |
| Q4 '23 | 84.0M |
| Q1 '24 | 84.0M |
| Q2 '24 | 83.4M |
| Q3 '24 | 83.1M |
| Q4 '24 | 82.6M |
| Q1 '25 | 81.9M |
| Q2 '25 | 81.0M |
| Q3 '25 | 80.7M |
| Q4 '25 | 80.5M |
| Q1 '26 | 80.2M |
| Q2 '26 | 79.3M |
$347Mlast quarter (Q2 2026)
$1.1Bnet of stock compensation ($63M)
−2.1%diluted shares, 1 year
−6.6%diluted shares, 5 years
—dividends, 12 months
94%of free cash flow ($1.3B) spent on buybacks
$0raised by issuing stock, 12 months
78.8Mshares outstanding (Jul 31, 2026)
Share counts are adjusted for a stock split (2-for-1).
By fiscal year
Questions
- Does Idexx Laboratories buy back its stock?
- Idexx Laboratories bought back $1.2B of its stock in the last twelve months, $1.1B more than it paid out in stock compensation. Its share count is down 2.1% from a year earlier.
- How much did Idexx Laboratories spend on buybacks in fiscal 2025?
- $1.2B, according to its 10-K for the fiscal year ending Dec 31, 2025.
- Is Idexx Laboratories's share count going down?
- Its diluted share count changed −6.6% over five fiscal years and −2.1% over the last year.
Latest filing used: 10-Q for the period ending Jun 30, 2026, filed Aug 4, 2026 · open on SEC.gov